Diabetes: one part of the cardiovascular problem post-transplant.
Luxon
Alesha
A
Astellas Pharma US Inc., Deerfield, IL, USA.
First
M Roy
MR
D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D015994:Incidence; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D008403:Mass Screening; D018579:Patient Selection; D019990:Perioperative Care / Q000379:methods; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D016559:Tacrolimus / Q000009:adverse effects; D014481:United States / Q000453:epidemiology
D007166:Immunosuppressive Agents; D016559:Tacrolimus